Symptom-cluster pattern most consistent with neuroinflammation, with secondary mitochondrial dysfunction signals. Recovery stage: partial regression. This is a pattern for clinical review — not a diagnosis.
| Marker | Result | Band |
|---|---|---|
| wbc | 3.2 | low |
| lymphocytes | 52 | high |
| crp | 4 | high |
| esr | 22 | high |
| vitamin d | 27 | low |
| ast | 44 | high |
| alt | 48 | high |
No high or critical safety flags. Overall risk 0/100 (Low Review Priority).
Clinical decision-support only — not a diagnosis. Axiom recognizes symptom-cluster patterns and organizes evidence. Scores are heuristic and attributable. They do not diagnose, interpret labs in isolation, or recommend or dose treatment. All clinical decisions rest with the reviewing physician.